000 | 02015 a2200529 4500 | ||
---|---|---|---|
005 | 20250516074124.0 | ||
264 | 0 | _c20121010 | |
008 | 201210s 0 0 eng d | ||
022 | _a1476-3524 | ||
024 | 7 |
_a10.1007/s12640-012-9311-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLopes, Fernanda Martins | |
245 | 0 | 0 |
_aEvaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine. _h[electronic resource] |
260 |
_bNeurotoxicity research _cAug 2012 |
||
300 |
_a138-49 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aAntiparkinson Agents _xpharmacology |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 | _aColoring Agents |
650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
650 | 0 | 4 |
_aGlutathione _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeurites _xdrug effects |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 | _aNeuroprotective Agents |
650 | 0 | 4 |
_aNeurotoxicity Syndromes _xpathology |
650 | 0 | 4 |
_aOrganoselenium Compounds _xpharmacology |
650 | 0 | 4 |
_aOxidopamine _xantagonists & inhibitors |
650 | 0 | 4 |
_aSympatholytics _xantagonists & inhibitors |
650 | 0 | 4 | _aTetrazolium Salts |
650 | 0 | 4 | _aThiazoles |
700 | 1 | _aLondero, Giovana Ferreira | |
700 | 1 | _ade Medeiros, Liana Marengo | |
700 | 1 | _ada Motta, Leonardo Lisbôa | |
700 | 1 | _aBehr, Guilherme Antônio | |
700 | 1 | _ade Oliveira, Valeska Aguiar | |
700 | 1 | _aIbrahim, Mohammad | |
700 | 1 | _aMoreira, José Cláudio Fonseca | |
700 | 1 | _aPorciúncula, Lisiane de Oliveira | |
700 | 1 | _ada Rocha, João Batista Teixeira | |
700 | 1 | _aKlamt, Fábio | |
773 | 0 |
_tNeurotoxicity research _gvol. 22 _gno. 2 _gp. 138-49 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12640-012-9311-1 _zAvailable from publisher's website |
999 |
_c21485793 _d21485793 |